Molecular mechanism of AMPA receptor noncompetitive antagonism
- PMID: 16242408
- DOI: 10.1016/j.neuron.2005.09.024
Molecular mechanism of AMPA receptor noncompetitive antagonism
Abstract
AMPA-type glutamate receptors are specifically inhibited by the noncompetitive antagonists GYKI-53655 and CP-465,022, which act through sites and mechanisms that are not understood. Using receptor mutagenesis, we found that these antagonists bind at the interface between the S1 and S2 glutamate binding core and channel transmembrane domains, specifically interacting with S1-M1 and S2-M4 linkers, thereby disrupting the transduction of agonist binding into channel opening. We also found that the antagonists' affinity is higher for agonist-unbound receptors than for activated nondesensitized receptors, further depending on the level of S1 and S2 domain closure. These results provide evidence for substantial conformational changes in the S1-M1 and S2-M4 linkers following agonist binding and channel opening, offering a conceptual frame to account for noncompetitive antagonism of AMPA receptors.
Similar articles
-
Stargazin modulates AMPA receptor antagonism.Neuropharmacology. 2008 Jun;54(7):1062-70. doi: 10.1016/j.neuropharm.2008.02.012. Epub 2008 Mar 4. Neuropharmacology. 2008. PMID: 18378265
-
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.Neuron. 2016 Sep 21;91(6):1305-1315. doi: 10.1016/j.neuron.2016.08.012. Epub 2016 Sep 8. Neuron. 2016. PMID: 27618672 Free PMC article.
-
Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function.J Neurosci. 2005 Mar 2;25(9):2215-25. doi: 10.1523/JNEUROSCI.4573-04.2005. J Neurosci. 2005. PMID: 15745947 Free PMC article.
-
Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.Mini Rev Med Chem. 2001 Sep;1(3):243-53. doi: 10.2174/1389557013406783. Mini Rev Med Chem. 2001. PMID: 12369971 Review.
-
2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.Neurochem Int. 2008 Jan;52(1-2):166-83. doi: 10.1016/j.neuint.2007.07.002. Epub 2007 Jul 10. Neurochem Int. 2008. PMID: 17707550 Review.
Cited by
-
Multi-level control of ionotropic glutamate receptor function.Cellscience. 2009 Jul 27;6(1):79. Cellscience. 2009. PMID: 20151028 Free PMC article.
-
Transmembrane AMPA receptor regulatory proteins and cornichon-2 allosterically regulate AMPA receptor antagonists and potentiators.J Biol Chem. 2011 Apr 15;286(15):13134-42. doi: 10.1074/jbc.M110.212522. Epub 2011 Feb 22. J Biol Chem. 2011. PMID: 21343286 Free PMC article.
-
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors.PLoS One. 2017 Sep 8;12(9):e0184429. doi: 10.1371/journal.pone.0184429. eCollection 2017. PLoS One. 2017. PMID: 28886144 Free PMC article.
-
Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.Mol Pharmacol. 2013 May;83(5):1045-56. doi: 10.1124/mol.113.085209. Epub 2013 Mar 1. Mol Pharmacol. 2013. PMID: 23455314 Free PMC article.
-
Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.J Biol Chem. 2010 Mar 5;285(10):7619-32. doi: 10.1074/jbc.M109.057182. Epub 2009 Dec 23. J Biol Chem. 2010. PMID: 20032460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
